SZABO-SCANDIC is pleased to announce that Europa Biosite Expands UK Presence with the Acquisition of Stratech Scientific.
Europa Biosite has announced the acquisition of Stratech Scientific through its UK subsidiary, Cambridge Bioscience. This strategic move further reinforces Europa Biosite’s position in the UK life science market and significantly broadens its research product portfolio.
Stratech Scientific is a well-established and highly respected UK distributor of life science reagents, known for its high-quality research products, long-standing supplier partnerships, and strong relationships within academic and industrial research communities.
Expanded Product Portfolio for UK Researchers
By integrating Stratech Scientific into Cambridge Bioscience, Europa Biosite enhances its ability to serve universities, biotechnology companies, and pharmaceutical research organizations across the United Kingdom.
The combined organization will offer:
- A substantially expanded life science reagent and research product catalogue
- Broader national customer coverage across academic and industrial research sectors
- Increased commercial opportunities for global suppliers through a unified and scalable UK platform
This complementary portfolio integration strengthens product availability, technical expertise, and customer support services throughout the UK market.
Strategic Growth Across Europe
The acquisition aligns with Europa Biosite’s long-term strategy to build a high-performance, pan-European life science distribution network. Through targeted acquisitions and a strong focus on commercial excellence, the group continues to expand its footprint in key European markets.
Adding Stratech Scientific represents another meaningful milestone in Europa Biosite’s growth journey. It reinforces the company’s ambition to provide one of the most comprehensive life science reagent portfolios in Europe while remaining a preferred partner for both suppliers and researchers.
With an active M&A-driven expansion strategy, Europa Biosite continues to explore new acquisition opportunities to strengthen its presence across Europe.
“After 43 years leading Stratech Scientific, I am delighted to announce that we have joined Europa Biosite. Stratech Scientific and Cambridge Bioscience have grown in parallel for decades, sharing the same commitment to enabling scientific discovery.By combining our portfolios and customer reach with Cambridge Bioscience, we will create expanded opportunities for our suppliers while providing our customers with access to a broader range of products and an even stronger level of service. This partnership is built on shared values, experience and a joint commitment to supporting the UK research community.”
Sue Hallett Managing Director of Stratech Scientific
“This acquisition represents an important strategic step for Europa Biosite. Integrating Stratech Scientific’s established product lines and customer relationships with Cambridge Bioscience reinforces our marketleading position in the UK. It directly aligns with our ambition to offer the most comprehensive life science reagent portfolio in Europe and to be the partner of choice for suppliers and researchers. Expanding our reach and strengthening supplier relationships across key European markets remains a central objective for 2026.”
Tim Hiddemann CEO of Europa Biosite
For more information, visit:
https://www.europabiosite.com/europa-biosite-acquires-stratech-scientific
Deutsch